The clinical distribution and drug resistance analysis of 168 Staphylococcus aureus isolated strains

Zhang Heping,Wang Ping,Gan Qiang,Li Yang,Wu Chunxiu
DOI: https://doi.org/10.3969/j.issn.1673-4130.2013.24.040
2013-01-01
Abstract:Objective To understand the hospital clinical distribution and drug resistance of Staphylococcus aureus,so as to guide clinical rational drug use and to reduce the generation of drug-resistant strains.Methods Bacteria culture,identification and drug sensitive test of qualified clinical specimens were processed by VITEK 2Compact automatic microbial analysis system.Results 168strains of Staphylococcusaureuswere isolated from all the specimens,including 59strains of methicillin-resistant Staphylococcus aureus(MRSA)with the detection rate of 35.1%(59/168).The isolated strains of Staphylococcus aureus mainly came from secretion specimens[51.2%(86/168)],sputum[22.0%(37/168)],whole blood[5.4%(9/168)],and catheter liquid[5.4%(9/ 168)].MRSA mainly distributed in departments of neurological(30.5%),general urologist(22.0%),orthopedic(15.2%),cardiothoracic surgery(8.5%),and respiratory(8.5%).The durg resistant rates of MRSA and non-methicillin-resistant Staphylococcus aureus(MSSA)were zero to vancomycin,linezolid,teicoplanin,quinupristin/dalfopristin and furantoin.The drug resistant rates of MRSA to penicillin and compound sulfamethoxazole were 100.0%and 6.8%respectively,and which were 91.7% and 12.8%respectively in MSSA.MRSA had higher drug resistant rates to the other nine kinds of antimicrobial drugs than MSSA.Conclusion It is helpful for infection controlling to enhance drug resistant strain monitoring and standarding clinical medication.
What problem does this paper attempt to address?